Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 1998

View Archived Issues

YM-175 treatment reduces alveolar bone loss in dogs with periodontitis

Incyte to acquire Hexagen and its technology for detecting SNPs

International team identifies compounds for treating slow-growing tumors

Life Medical Sciences: Q2 1998 highlights

GelTex: Q2 1998 highlights

Aphton patents its vaccine-like technology based on the neutralization of gastrin

Rebetron receives priority review status

Antidiabetes drug from Amylin enters phase I clinical study

Incert appears to prevent the formation of postoperative adhesions

Pagoclone reduces frequency of panic attacks in patients with panic disorder

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Pfizer discovers new treatments for atherosclerosis and related disorders

Allelix research into antimigraine compounds proves fruitful

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

News from ACS: PD-180988 is a potent and selective ETA antagonist

Selective MMP-3 inhibitor PS-508 described at ACS meeting

SSRI produces significant improvements in patients with social phobia

Agouron's HIV protease inhibitor approved for marketing in Canada

Bio-Technology General in-licenses PEG-uricase for development

IMpact-RSV trial results announced at international congress

Advisory committee recommends European approval for Viagra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...